arXiv:2512.00713v2 Announce Type: replace-cross Abstract: Vision-Language Models (VLMs) have achieved impressive progress in multimodal text generation, yet their rapid adoption raises increasing concerns about security vulnerabilities. Existing backdoor attacks against VLMs primarily rely on explicit pixel-level triggers or imperceptible perturbations injected into images. While effective, these approaches reduce stealthiness and remain vulnerable to image-based defenses. We introduce concept-guided backdoor attacks, a new paradigm that operates at the semantic concept level rather than on raw pixels. We propose two different attacks. The first, Concept-Thresholding Poisoning (CTP), uses explicit concepts in natural images as triggers: only samples containing the target concept are poisoned, causing the model to behave normally in all other cases but consistently inject malicious outputs whenever the concept appears. The second, CBL-Guided Unseen Backdoor (CGUB), leverages a Concept Bottleneck Model (CBM) during training to intervene on internal concept activations, while discarding the CBM branch at inference time to keep the VLM unchanged. This design enables systematic replacement of a targeted label in generated text (for example, replacing "cat" with "dog"), even when the replacement behavior never appears in the training data. Experiments across multiple VLM architectures and datasets show that both CTP and CGUB achieve high attack success rates while maintaining moderate impact on clean-task performance. These findings highlight concept-level vulnerabilities as a critical new attack surface for VLMs.

arXiv:2510.20448v2 Announce Type: replace-cross Abstract: Drug combinations offer therapeutic benefits but also carry the risk of adverse drug-drug interactions (DDIs), especially under complex molecular structures. Accurate DDI event prediction requires capturing fine-grained inter-drug relationships, which are critical for modeling metabolic mechanisms such as enzyme-mediated competition. However, existing approaches typically rely on isolated drug representations and fail to explicitly model atom-level cross-molecular interactions, limiting their effectiveness across diverse molecular complexities and DDI type distributions. To address these limitations, we propose MolBridge, a novel atom-level joint graph refinement framework for robust DDI event prediction. MolBridge constructs a joint graph that integrates atomic structures of drug pairs, enabling direct modeling of inter-drug associations. A central challenge in such joint graph settings is the potential loss of information caused by over-smoothing when modeling long-range atomic dependencies. To overcome this, we introduce a structure consistency module that iteratively refines node features while preserving the global structural context. This joint design allows MolBridge to effectively learn both local and global interaction outperforms state-of-the-art baselines, achieving superior performance across long-tail and inductive scenarios. patterns, yielding robust representations across both frequent and rare DDI types. Extensive experiments on two benchmark datasets show that MolBridge consistently. These results demonstrate the advantages of fine-grained graph refinement in improving the accuracy, robustness, and mechanistic interpretability of DDI event prediction.This work contributes to Web Mining and Content Analysis by developing graph-based methods for mining and analyzing drug-drug interaction networks.

arXiv:2510.20448v1 Announce Type: cross Abstract: Drug combinations offer therapeutic benefits but also carry the risk of adverse drug-drug interactions (DDIs), especially under complex molecular structures. Accurate DDI event prediction requires capturing fine-grained inter-drug relationships, which are critical for modeling metabolic mechanisms such as enzyme-mediated competition. However, existing approaches typically rely on isolated drug representations and fail to explicitly model atom-level cross-molecular interactions, limiting their effectiveness across diverse molecular complexities and DDI type distributions. To address these limitations, we propose MolBridge, a novel atom-level joint graph refinement framework for robust DDI event prediction. MolBridge constructs a joint graph that integrates atomic structures of drug pairs, enabling direct modeling of inter-drug associations. A central challenge in such joint graph settings is the potential loss of information caused by over-smoothing when modeling long-range atomic dependencies. To overcome this, we introduce a structure consistency module that iteratively refines node features while preserving the global structural context. This joint design allows MolBridge to effectively learn both local and global interaction outperforms state-of-the-art baselines, achieving superior performance across long-tail and inductive scenarios. patterns, yielding robust representations across both frequent and rare DDI types. Extensive experiments on two benchmark datasets show that MolBridge consistently. These results demonstrate the advantages of fine-grained graph refinement in improving the accuracy, robustness, and mechanistic interpretability of DDI event prediction.This work contributes to Web Mining and Content Analysis by developing graph-based methods for mining and analyzing drug-drug interaction networks.